ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases
ImmunoPrecise Antibodies Ltd. (IPA)
Company Research
Source: Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, is pleased to announce significant insider activity, with key members of its executive team and subsidiary co-founders demonstrating confidence in the Company’s strategic direction and long-term potential through substantial share purchases.Over the past week, CEO Dr. Jennifer Bath and BioStrand co-founders Dirk Van Hyfte and Ingrid Brands collectively acquired a total of 763,120 shares of IPA on the open market for an aggregate amount of USD $306,000.A Strong Signal of ConfidenceThis insider activity highlights the leadership team’s belief in IPA’s growth trajectory and transformational initiatives. Dr. Bath commented, “Our collective investments reflect our deep confidence in IPA’s vision and our commitment to driving long-term value for our shareholders. As we advance groundbreaking initiatives in A
Show less
Read more
Impact Snapshot
Event Time:
IPA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPA alerts
High impacting ImmunoPrecise Antibodies Ltd. news events
Weekly update
A roundup of the hottest topics
IPA
News
- ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases [Yahoo! Finance]Yahoo! Finance
- IPA to Present at The Microcap Conference 2025Accesswire
- IPA to Present at The Microcap Conference 2025 [Yahoo! Finance]Yahoo! Finance
- IPA to Present at The Microcap Conference 2025Business Wire
- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its price target lowered by analysts at HC Wainwright from $9.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
IPA
Earnings
- 12/10/24 - Miss
IPA
Sec Filings
- 12/23/24 - Form 6-K
- 12/10/24 - Form 6-K
- 12/10/24 - Form 20-F/A
- IPA's page on the SEC website